Changes in structure and symptoms in knee osteoarthritis and prediction of future knee replacement over 8 years

Calcified Tissue International

Volumn 93, Issue 6, 2013, Pages 502-507

  Bruyere, Olivier ^a   Cooper, Cyrus ^b,c   Pavelka, Karel ^d   Rabenda, Véronique ^a   Buckinx, Fanny ^a   Beaudart, Charlotte ^a   Reginster, Jean Yves ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Joint space width; Knee osteoarthritis; Knee replacement; Prognosis; WOMAC score

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; JOINT CAVITY; JOINT SPACE WIDTH; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SYMPTOMATOLOGY; TISSUE STRUCTURE; TREATMENT PLANNING; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

AGED; ARTHROPLASTY, REPLACEMENT, KNEE; BODY MASS INDEX; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FEMUR; FOLLOW-UP STUDIES; HUMANS; KNEE JOINT; LOGISTIC MODELS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIBIA;

EID: 84889084271     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-013-9781-z     Document Type: Article

References (23)

1. European Medicines Agency (2010) Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis. www.ema.europa.eu. Accessed 18 Jan 2013
2. Food and Drug Administration (2011) Guidance for industry. Clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis. www.fda.gov. Accessed 18 Jan 2013
3. Beaton DE, Bombardier C, Katz JN, Wright JG (2001) A taxonomy for responsiveness. J Clin Epidemiol 54:1204-1217
4. Ornetti P, Brandt K, Hellio-Le Graverand MP, Hochberg M, Hunter DJ, Kloppenburg M, Lane N, Maillefert JF, Mazzuca SA, Spector T, Utard-Wlerick G, Vignon E, Dougados M (2009) OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthritis Cartilage 17:856-863
5. Manno RL, Bingham CO 3rd, Paternotte S, Gossec L, Halhol H, Giacovelli G, Rovati L, Mazzuca SA, Clegg DO, Shi H, Tajana Messi E, Lanzarotti A, Dougados M (2012) OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials. Osteoarthritis Cartilage 20:93-101
6. Gossec L, Paternotte S, Bingham CO 3rd, Clegg DO, Coste P, Conaghan PG, Davis AM, Giacovelli G, Gunther KP, Hawker G, Hochberg MC, Jordan JM, Katz JN, Kloppenburg M, Lanzarotti A, Lim K, Lohmander LS, Mahomed NN, Maillefert JF, Manno RL, March LM, Mazzuca SA, Pavelka K, Punzi L, Roos EM, Rovati LC, Shi H, Singh JA, Suarez-Almazor ME, Tajana-Messi E, Dougados M (2011) OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group. J Rheumatol 38:1765-1769
7. Cicuttini FM, Jones G, Forbes A, Wluka AE (2004) Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study. Ann Rheum Dis 63:1124-1127
8. Bruyere O, Richy F, Reginster JY (2005) Three year joint space narrowing predicts long term incidence of knee surgery in patients with osteoarthritis: an eight year prospective follow up study. Ann Rheum Dis 64:1727-1730
9. Tanamas SK, Wluka AE, Pelletier JP, Pelletier JM, Abram F, Berry PA, Wang Y, Jones G, Cicuttini FM (2010) Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study. Rheumatology (Oxford) 49:2413-2419
10. Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC (2002) Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 162:2113-2123
11. Bruyere O, Pavelka K, Rovati LC, Gatterova J, Giacovelli G, Olejarova M, Deroisy R, Reginster JY (2008) Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage 16:254-260
12. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039-1049
13. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833-1840
14. Cooper C, Adachi JD, Bardin T, Berenbaum F, Flamion B, Jonsson H, Kanis JA, Pelousse F, Lems WF, Pelletier JP, Martel-Pelletier J, Reiter S, Reginster JY, Rizzoli R, Bruyere O (2013) How to define responders in osteoarthritis. Curr Med Res Opin 29:719-729
15. Raynauld JP, Martel-Pelletier J, Haraoui B, Choquette D, Dorais M, Wildi LM, Abram F, Pelletier JP (2011) Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation. Ann Rheum Dis 70:1382-1388
16. Gossec L, Paternotte S, Maillefert JF, Combescure C, Conaghan PG, Davis AM, Gunther KP, Hawker G, Hochberg M, Katz JN, Kloppenburg M, Lim K, Lohmander LS, Mahomed NN, March L, Pavelka K, Punzi L, Roos EM, Sanchez-Riera L, Singh JA, Suarez-Almazor ME, Dougados M (2011) The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on Total Joint Replacement. Osteoarthritis Cartilage 19:147-154
17. Gossec L, Hawker G, Davis AM, Maillefert JF, Lohmander LS, Altman R, Cibere J, Conaghan PG, Hochberg MC, Jordan JM, Katz JN, March L, Mahomed N, Pavelka K, Roos EM, Suarez-Almazor ME, Zanoli G, Dougados M (2007) OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. J Rheumatol 34:1432-1435
18. Dougados M, Hawker G, Lohmander S, Davis AM, Dieppe P, Maillefert JF, Gossec L (2009) OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs. J Rheumatol 36:2097-2099
19. Maheu E, Cadet C, Marty M, Dougados M, Ghabri S, Kerloch I, Mazieres B, Spector TD, Vignon E, Lequesne MG (2005) Reproducibility and sensitivity to change of various methods to measure joint space width in osteoarthritis of the hip: a double reading of three different radiographic views taken with a three-year interval. Arthritis Res Ther 7:R1375-R1385
20. LaValley MP, McLaughlin S, Goggins J, Gale D, Nevitt MC, Felson DT (2005) The lateral view radiograph for assessment of the tibiofemoral joint space in knee osteoarthritis: its reliability, sensitivity to change, and longitudinal validity. Arthritis Rheum 52:3542-3547
21. Ravaud P, Giraudeau B, Auleley GR, Chastang C, Poiraudeau S, Ayral X, Dougados M (1996) Radiographic assessment of knee osteoarthritis: reproducibility and sensitivity to change. J Rheumatol 23:1756-1764
22. Hunter DJ, Zhang YQ, Tu X, Lavalley M, Niu JB, Amin S, Guermazi A, Genant H, Gale D, Felson DT (2006) Change in joint space width: hyaline articular cartilage loss or alteration in meniscus? Arthritis Rheum 54:2488-2495
23. Robine JM, Cambois E, Nusselder W, Jeune B, Oyen HV, Jagger C (2013) The joint action on healthy life years (JA: EHLEIS). Arch Public Health 71:2